Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction.

Not Applicable

• Conditions: F20; F25; F10-F19; Schizophrenia; Schizoaffective disorders; Mental and behavioural disorders due to psychoactive substance use

• Registration Number: DRKS00000671
• Lead Sponsor: Klinik für Psychiatrie und Psychotherapie Uniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03-02
• Study Completion: 2013-07-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. schizophrenic patients
2. acceptance
3. majority

Exclusion Criteria

1. no acceptance because of positive symptoms
2. neuopsychiatric disorders
3. no acceptance of the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- change/reduction of drug consumption<br>- motivation of change the drug consumption<br><br>quesstionaries: criteries of their drugs, motivation of change<br>

Secondary Outcome Measures

Name	Time	Method
- psychosis symptoms<br>- Number/duration of inpatient treatment<br>- depressive symptoms<br>- General health <br>- Compliance: Stay in the treatment program (drop-out rates) and especially Medikamteneimnmahme <br>- Subjective life satisfaction <br>- Amount of general psychosocial functioning level <br>- Self-efficacy <br>- Self-assessment resources <br>- Treatment satisfaction<br><br><br>questionaries: <br>demographic, diagnosis, psychosis, SKID-II, depression (MADRS), compliance, medication (GAF - Global assessment of functioning), Subjective life satisfaction (FLZ), Social control (F-SozU), Self-efficacy (SWE), resources (RES-K), treatment satisfaction (ZUF-8)